Bringing the fundamentals into focus…
Back to Arcutis Biotherapeutics, Inc.
How Arcutis Biotherapeutics, Inc. stacks up
ARQT · against 259 other Healthcare companies of similar size
Profitability
64/ 100
Below the middle of the pack.
Ranked #132 of 260 · scores higher than 49% of peers
Bars: peers in each 10-point band of the profitability score28 peers with a profitability score of 60–69, including ARQT · Click a bar to see the companies
Why profitability scores 64?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on assets and return on invested capital, which are stronger than most Healthcare peers.
- Operating margin is close to the peer norm. Operating margin: 7.4% vs peer median 7.1%
- a higher return on invested capital: stronger than 65% of peers. Return on invested capital: 9.2% vs peer median 4.7%
- a higher return on assets: stronger than 76% of peers. Return on assets: 5.8% vs peer median 1.7%
Metric by metric
Position: dot = ARQT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARQT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 250 reported | 9.2% | 8.2% | 53% | 33% | |
| Operating marginHigher is better · 237 reported | 7.4% | 10.5% | 39% | 33% | |
| Return on assetsHigher is better · 247 reported | 5.8% | 3.3% | 70% | 33% | |
| Return on equityHigher is better · 243 reported | 15.9% | 7.5% | 78% | Context only | |
| Gross marginHigher is better · 267 reported | 91.1% | 48.4% | 94% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ARQT| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 4 | 3.8B USD | 99 | 71 | |
| 128 | 17.9B CNY (≈$2.5B) | 65 | 62 | |
| 128 | 488.5B JPY (≈$3.3B) | 65 | 72 | |
| 128 | 2.8B SGD (≈$2.2B) | 65 | 67 | |
| 128 | 5.3B USD | 65 | 63 | |
| 132 | 4.0B USD | 64 | 56 | |
| 133 | 16.3B CNY (≈$2.3B) | 63 | 49 | |
| 133 | 3.1B EUR (≈$3.4B) | 63 | 42 | |
| 133 | 593.2B INR (≈$7.1B) | 63 | 47 | |
| 133 | 1.6B GBP (≈$2.1B) | 63 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score